Shigellosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
YazanDaaboul (talk | contribs)
Bots, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, oversight, smwadministrator, Administrators, Widget editors
9,960 edits
YazanDaaboul (talk | contribs)
Bots, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, oversight, smwadministrator, Administrators, Widget editors
9,960 edits
Line 18: Line 18:


==Complications==
==Complications==
Complications are generally rare among immunocompetent individuals. The risk of complications increases among HIV-positive individuals and among young children. Approximately 1 of 10 children develop complications of shigellosis.
[[Reiter's syndrome]] is a late complication of ''S. flexneri'' infection, especially in persons with the genetic marker HLA-B27. [[Hemolytic-uremic syndrome]] can occur after ''S. dysenteriae'' type 1 infection. [[Convulsions]] may occur in children; the mechanism may be related to a rapid rate of temperature elevation or metabolic alterations
[[Reiter's syndrome]] is a late complication of ''S. flexneri'' infection, especially in persons with the genetic marker HLA-B27. [[Hemolytic-uremic syndrome]] can occur after ''S. dysenteriae'' type 1 infection. [[Convulsions]] may occur in children; the mechanism may be related to a rapid rate of temperature elevation or metabolic alterations
<ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm </ref>
<ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm </ref>


* Intestinal Complications (Rare)
===Intestinal Complications<ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm </ref>===
*:* [[Rectal prolapse]], [[proctitis]]
*[[Rectal prolapse]]
*:* [[Toxic Megacolon]]
*[[proctitis]]
*:* [[Colonic Perforation]]
*[[Toxic Megacolon]]
* Systemic Complications
*[[Colonic Perforation]]
*:* [[Bacteremia]] ([[gram-negative]] rod's (GNR’s), not just [[Shigella]])
*:* [[Hyponatremia]] ([[syndrome of inappropriate antidiuretic hormone]] secretion ([[SIADH]])
*:* [[Leukemoid Reactions]]
*:* [[Seizure]]
*:* [[Reactive Arthritis]]
* [[Hemolytic Uremic Syndrome]]
*:* MAHA ([[microangiopathic hemolytic anemia]])
*:* [[Thrombocytopenia]]
*:* [[Acute Renal Failure]]<ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm </ref><ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_g.htm </ref>


About 1 in 10 children with severe shigella enteritis develop neurological problems including [[febrile seizures]] or brain disease ([[encephalopathy]]) with [[headache]], [[lethargy]], [[confusion]], and stiff neck.
===Systemic Complications<ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm </ref>===
*[[Post-infectious arthritis]] (Reiter's syndrome)
**Approximately 2% of individuals infected with ''S. flexneri'' develop Reiter's syndrome (Triad of arthritis, uveitis, and urethritis).
**Post-infectious arthritis may persist for several weeks to months and may become chronic.
**Individuals with HLA-B27 subtype are predisposed to development of Reiter's syndrome following shigellosis.
*[[Bacteremia]]
**Bacteremia is common among immunocompromised individuals, such as HIV-positive individuals and individuals with cancer and malnutrition.
*[[SIADH]] and SIADH-associated hyponatremia
*[[Seizure]]
**Febrile seizres are common among children less than 2 years of age.
*[[Encephalopathy]] (especially among children)
*[[Reactive arthritis]]
*[[Hemolytic uremic syndrome]] (HUS)
**HUS is mediated by shiga-toxin that is typically present in ''S. dysenteriae''.
*[[Microangiopathic hemolytic anemia]] (MAHA)
*[[Thrombocytopenia]]
*[[Acute Renal Failure]]<ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm </ref><ref>http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_g.htm </ref>


==Prognosis==
==Prognosis==

Revision as of 01:14, 6 April 2015

Shigellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Shigellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Shigellosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Shigellosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Shigellosis natural history, complications and prognosis

CDC on Shigellosis natural history, complications and prognosis

Shigellosis natural history, complications and prognosis in the news

Blogs on Shigellosis natural history, complications and prognosis

Directions to Hospitals Treating Shigellosis

Risk calculators and risk factors for Shigellosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Infections are associated mucosal ulceration, rectal bleeding, drastic dehydration; fatality may be as high as 10-15% with some strains. Reiter's disease, reactive arthritis, and hemolytic uremic syndrome are possible sequelae that have been reported in the aftermath of shigellosis.

Natural History

Ingestion of Shigella

  • Not all individuals develop clinical manifestations of shigellosis. Individuals may remain asymptomatic but transmit the organism to other individuals.

Development of Clinical Manifestations

  • Clinical manifestations of shigellosis typically appear approximately 12 hours to 3 days following ingestion of Shigella".
  • Patients generally first develop colicky diffuse abdominal pains associated with nausea and fever.
  • Diarrhea and tenesmus (rectal spasms) typically follow. Diarrhea is often reported to be small in volume and may range from mild to severe. The majority of patients report mucus in stools, and up to half of infected patients report bloody stools. Children younger than 2 years of age may develop high-grade fevers and febrile seizures.

Resolution of Clinical Manifestations

  • If left untreated, clinical manifestations of shigellosis typically self-resolve within 5 to 7 days of development of clinical manifestations.
  • In immunocompromised individuals and young children, shigellosis may be more severe and prolonged, necessitating hospitalization to reduce the risk of shigella-associated complications.

Complications

Complications are generally rare among immunocompetent individuals. The risk of complications increases among HIV-positive individuals and among young children. Approximately 1 of 10 children develop complications of shigellosis.

Reiter's syndrome is a late complication of S. flexneri infection, especially in persons with the genetic marker HLA-B27. Hemolytic-uremic syndrome can occur after S. dysenteriae type 1 infection. Convulsions may occur in children; the mechanism may be related to a rapid rate of temperature elevation or metabolic alterations [1]

Intestinal Complications[2]

Systemic Complications[3]

  • Post-infectious arthritis (Reiter's syndrome)
    • Approximately 2% of individuals infected with S. flexneri develop Reiter's syndrome (Triad of arthritis, uveitis, and urethritis).
    • Post-infectious arthritis may persist for several weeks to months and may become chronic.
    • Individuals with HLA-B27 subtype are predisposed to development of Reiter's syndrome following shigellosis.
  • Bacteremia
    • Bacteremia is common among immunocompromised individuals, such as HIV-positive individuals and individuals with cancer and malnutrition.
  • SIADH and SIADH-associated hyponatremia
  • Seizure
    • Febrile seizres are common among children less than 2 years of age.
  • Encephalopathy (especially among children)
  • Reactive arthritis
  • Hemolytic uremic syndrome (HUS)
    • HUS is mediated by shiga-toxin that is typically present in S. dysenteriae.
  • Microangiopathic hemolytic anemia (MAHA)
  • Thrombocytopenia
  • Acute Renal Failure[4][5]

Prognosis

Often the infection is mild and goes away on its own. Most patients, except malnourished children and those with weakened immune systems, have an excellent outlook.

References

  1. ↑ http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm
  2. ↑ http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm
  3. ↑ http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm
  4. ↑ http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm
  5. ↑ http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_g.htm


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Shigellosis_natural_history,_complications_and_prognosis&oldid=1082934"